Social Media Ideas for Nrxp

Latest updates for Nrxp

Fresh curated links around NRXP are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /1 month ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source

seekingalpha.com /1 month ago

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Read source

seekingalpha.com /1 month ago

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty

Read source

seekingalpha.com /4 weeks ago

Nexxen International Ltd. (NEXN) Analyst/Investor Day Transcript

Read source

seekingalpha.com /3 weeks ago

Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton

Read source

newswire.com /1 month ago

NYMOX Provides Current Update

Read source

seekingalpha.com /1 week ago

RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript

Read source

investing.com /1 month ago

RenovoRx reports pharmacokinetic data from pancreatic trial

Read source

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

fool.com /1 month ago

RXO Stock Has Surged 75% Since This Fund Made a $10 Million Bet

RXO uses a digital freight marketplace to deliver asset-light logistics and transportation solutions across multiple U.S. industries.

Read source

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

seekingalpha.com /2 weeks ago

Lantheus receives Complete Response Letter for LNTH-2501

Read source

cafepharma.com /2 weeks ago

Expansion

Expansion Anonymous (not verified) Mon, 06/29/2026 - 03:04 field_thread_url https://cafepharma.com/boards/threads/expansion.701787/ boar...

Read source

seekingalpha.com /1 month ago

NexPoint Residential Trust, Inc. (NXRT) Presents at Nareit REITweek: 2026 Investor Conference - Slideshow

Read source

seekingalpha.com /2 weeks ago

Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic A...

Read source

finance.yahoo.com /3 weeks ago

Niagen Bioscience Inc. (NAGE) Renames Research Program Amid Focus in Advancing NAD+ Applications

Read source

fiercebiotech.com /4 weeks ago

Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup

Innoviva has revealed the next steps for Langer Lab assets it rescued from Lyndra Therapeutics’ collapse, launching Nortiva Bio to develop long-acting oral medicines and pursue dru...

Read source

seekingalpha.com /1 month ago

Ionis Pharmaceuticals: Bull Run Can Continue As Major Catalysts Approach

Read source

fool.com /1 month ago

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.

Read source

fool.com /1 month ago

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.

Read source

seekingalpha.com /1 month ago

Neurocrine Biosciences, Inc. (NBIX) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Read source

cafepharma.com /3 weeks ago

Expansion

Expansion Anonymous (not verified) Thu, 06/25/2026 - 03:02 field_thread_url https://cafepharma.com/boards/threads/expansion.701787/ boar...

Read source

seekingalpha.com /1 month ago

NextCure, Inc. (NXTC) Discusses Preliminary Phase I Data for SIM0505 in Platinum-Resistant Ovarian Cancer and Uterine Se...

Read source

seekingalpha.com /1 month ago

Nextpower Inc. (NXT) M&A Call Transcript

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.